Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0557 in Obese Patients
NCT00092859Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing MK-0557 with Placebo (2 arms). Primary endpoints: Body weight after 1 year of treatment and Safety and tolerability for 2 years. Started Aug 2003; status: completed.
02
Drugs
MK-0557
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00092859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092859.